Kox Med And Lab Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 5.00 M
as on 24-10-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.81 Cr
as on 24-10-2024
- Satisfied Charges ₹ 46.53 Cr
as on 24-10-2024
- Revenue 54.32%
(FY 2023)
- Profit 12.64%
(FY 2023)
- Ebitda 8.79%
(FY 2023)
- Net Worth 5.96%
(FY 2023)
- Total Assets 23.43%
(FY 2023)
About Kox Med And Lab
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹40.81 Cr. The company has closed loans amounting to ₹46.53 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kapil Suri and Davindra Suri serve as directors at the Company.
- CIN/LLPIN
U74899DL2004PTC125273
- Company No.
125273
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kox Med And Lab Private Limited offer?
Kox Med And Lab Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Patient Monitoring System, Material Testing Labs & Services, Laboratory Testing Services.
Who are the key members and board of directors at Kox Med And Lab?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kapil Suri  | Director | 18-Mar-2004 | Current |
| Davindra Suri | Director | 01-Apr-2005 | Current |
Financial Performance of Kox Med And Lab.
Kox Med And Lab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 54.32% increase. The company also saw a substantial improvement in profitability, with a 12.64% increase in profit. The company's net worth moved up by a moderate rise of 5.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kox Med And Lab?
In 2022, Kox Med And Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Jul 2023 | ₹1.02 Cr | Open |
Others Creation Date: 04 Jul 2023 | ₹1.79 Cr | Open |
Others Creation Date: 04 Jul 2023 | ₹38.00 Cr | Open |
How Many Employees Work at Kox Med And Lab?
Kox Med And Lab has a workforce of 20 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kox Med And Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kox Med And Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
